Publication | Closed Access

CD34, CD4, and CD8 cell doses do not influence engraftment, graft-versus-host disease, or survival following myeloablative human leukocyte antigen-identical peripheral blood allografting for hematologic malignancies

Cd8 Cell DosesGraft-versus-host DiseaseTransplantationCell TherapyStem Cell TransplantationImmunologyHematologyHematologic MalignanciesAutoimmunityGraft SurvivalBlood TransplantationRadiation OncologyMedicineCell TransplantationGraft RejectionHealth Sciences